Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

A4L Announces Research Award from SOSCIP and OCE

Analytics 4 Life (A4L)
Posted on: 14 Sep 16

PR Newswire

TORONTO, Sept. 14, 2016

TORONTO, Sept. 14, 2016 /PRNewswire/ -- Today, Analytics 4 Life (A4L), a Toronto-based eHealth company, announced its second project award by Southern Ontario Smart Computing Innovation Platform (SOSCIP) and Ontario Centres of Excellence (OCE). The focus of the new project is to create a proprietary machine learning computational algorithm that can analyze physiologic signals and identify patterns related to heart disease.

SOSCIP is a research and development consortium that pairs academic and industry researchers with advanced computing tools to fuel innovation leadership in Canada. SOSIP and OCE granted access and funding for A4L's first research project that demonstrated the ability to predict hidden heart disease in controlled animal lab experiments. The results of A4L's initial research project in collaboration with Dr. Terrence Ozolins from Queen's University have been submitted for publication and are currently pending.

This second SOSCIP and OCE supported project will process billions of data points acquired from A4L's ongoing US-based multi-centre clinical study that is enrolling up to 2,500 subjects at as many as 25 sites. "Together, A4L and SOSCIP are exploring the use of advanced tools, such as IBM's BlueGene/Q supercomputing and the new Quantum Experience, to enable our scientists to investigate larger search spaces and find optimal solutions efficiently," says Sunny Gupta, A4L's Founder and Chief Scientific Officer.

Privately-held Analytics for Life Inc. was founded in 2012 as an information technology company and currently has offices in Toronto and the Research Triangle Park in North Carolina.   Don Crawford, A4L's CEO, says, "The support of SOSCIP and OCE has helped the company's Toronto-based technology development center rapidly expand to support the company's aggressive product development goals."

About A4L
Analytics 4 Life (A4L) Analytics 4 Life (A4L) is a Toronto-based eHealth company using advanced phase signal processing techniques for the purposes of identifying and assessing disease with an initial focus on coronary artery disease (CAD). Beyond coronary artery disease, A4L has started to apply its platform technology to address other disease states in cardiology as well as neurology and oncology.

About SOSCIP
Southern Ontario Smart Computing Innovation Platform (SOSCIP) is a research and development consortium that pairs academic and industry researchers with advanced computing tools to fuel innovation leadership in Canada. The consortium includes 15 universities as well as the Ontario Centres of Excellence and IBM Canada Research and Development Centre.

About OCE
Ontario Centres of Excellence (OCE) drives the development of Ontario's economy by helping create new jobs, products, services, technologies and businesses. OCE's efforts are focused on sectors of the economy with the greatest potential to drive Ontario's future prosperity and global competitiveness: energy and environment (including water); advanced manufacturing; advanced health technologies; and information, communications technologies and digital media.

Logo - http://photos.prnewswire.com/prnh/20160913/407112LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/a4l-announces-research-award-from-soscip-and-oce-300327868.html

SOURCE Analytics 4 Life (A4L)

PR Newswire
www.prnewswire.com

Last updated on: 14/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.